A detailed history of Security Asset Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Security Asset Management holds 9,230 shares of BMY stock, worth $529,155. This represents 0.37% of its overall portfolio holdings.

Number of Shares
9,230
Previous 7,672 20.31%
Holding current value
$529,155
Previous $551,000 15.97%
% of portfolio
0.37%
Previous 0.31%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $102,376 - $116,117
1,558 Added 20.31%
9,230 $639,000
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $23,968 - $28,381
-350 Reduced 4.36%
7,672 $551,000
Q2 2022

Aug 02, 2022

BUY
$72.62 - $79.98 $48,437 - $53,346
667 Added 9.07%
8,022 $618,000
Q2 2021

Jul 27, 2021

SELL
$61.91 - $67.42 $54,852 - $59,734
-886 Reduced 10.75%
7,355 $491,000
Q1 2021

Apr 29, 2021

BUY
$59.34 - $66.74 $178,020 - $200,219
3,000 Added 57.24%
8,241 $520,000
Q4 2020

Feb 01, 2021

BUY
$57.74 - $65.43 $191,754 - $217,293
3,321 Added 172.97%
5,241 $325,000
Q3 2020

Nov 02, 2020

SELL
$57.43 - $63.64 $129,964 - $144,017
-2,263 Reduced 54.1%
1,920 $116,000
Q2 2019

Aug 06, 2019

SELL
$44.62 - $49.34 $124,936 - $138,152
-2,800 Reduced 40.1%
4,183 $190,000
Q3 2018

Oct 26, 2018

SELL
$55.19 - $62.25 $22,076 - $24,900
-400 Reduced 5.42%
6,983 $434,000
Q1 2018

Apr 27, 2018

BUY
$59.92 - $68.98 $8,268 - $9,519
138 Added 1.9%
7,383 $467,000
Q3 2017

Nov 06, 2017

BUY
$55.23 - $63.74 $400,141 - $461,796
7,245
7,245 $462,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Security Asset Management Portfolio

Follow Security Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Security Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Security Asset Management with notifications on news.